Sanai Health Industry Group Company Limited (Sanai Health) filed its Monthly Return with Hong Kong Exchanges and Clearing on 6 July 2026, covering movements up to 30 June 2026.

Authorised Capital • Authorised share capital held steady at HKD 100.00 million, represented by 10.00 billion ordinary shares with a par value of HKD 0.01 each. • No changes were recorded during the month.

Issued and Treasury Shares • Issued shares remained unchanged at 152.90 million; the company held no treasury shares. • Consequently, total issued share capital stayed constant, and the public float comfortably satisfied the Main Board’s minimum 25 % requirement.

Share Option Scheme Activity • Under the share option scheme approved on 16 June 2017 and refreshed on 5 January 2022: – Outstanding options: 0.40 million, unchanged month-on-month. – No new shares were issued and no treasury shares were transferred. – A further 5.31 million shares remain available for future issue under the scheme.

Other Equity Instruments • The company reported no warrants, convertible securities, or other agreements that could impact share capital. • There were no share repurchases, cancellations, or other movements during the period.

Regulatory Confirmation • Director Xie Haijing confirmed that all share-related activities complied with Hong Kong listing rules and that all required filings and procedures were completed.

Overall, Sanai Health’s capital structure and share count were unchanged in June 2026, with continued adherence to public float regulations and limited outstanding equity-settled obligations.